8-K//Current report
InMed Pharmaceuticals Inc. 8-K
Accession 0001213900-25-098229
$INMCIK 0001728328operating
Filed
Oct 13, 8:00 PM ET
Accepted
Oct 10, 7:50 PM ET
Size
233.8 KB
Accession
0001213900-25-098229
Documents
- 8-Kea0261001-8k_inmed.htmPrimary
CURRENT REPORT
- EX-99.1ea026100101ex99-1_inmed.htm
SEDAR FILING SUBMITTED OCTOBER 10, 2025
- GRAPHICex99-1_001.jpg
GRAPHIC
- EX-101.SCHinm-20251010.xsd
XBRL SCHEMA FILE
- EX-101.DEFinm-20251010_def.xml
XBRL DEFINITION FILE
- EX-101.LABinm-20251010_lab.xml
XBRL LABEL FILE
- EX-101.PREinm-20251010_pre.xml
XBRL PRESENTATION FILE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001213900-25-098229-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLea0261001-8k_inmed_htm.xml
IDEA: XBRL DOCUMENT
Issuer
InMed Pharmaceuticals Inc.
CIK 0001728328
Entity typeoperating
IncorporatedBritish Columbia, Canada
Related Parties
1- filerCIK 0001728328
Filing Metadata
- Form type
- 8-K
- Filed
- Oct 13, 8:00 PM ET
- Accepted
- Oct 10, 7:50 PM ET
- Size
- 233.8 KB